Robert L. Carolla

A phase II evaluation of lapatinib in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: A gynecologic oncology group study

Agustin A. García, Michael W. Sill, Heather A. Lankes et al. · Gynecologic Oncology · 2011 · 121 citations · Full text

Medicine, Gynecology, Oncology +13

A phase III, randomized, placebo-controlled, double-blind trial of flaxseed for the treatment of hot flashes

Sandhya Pruthi, Rui Qin, Shelby A. Terstreip et al. · Menopause The Journal of The North American Menopause Society · 2011 · 76 citations · Full text

Medicine, Nutrition, Pharmacology +14

BONE MARROW TRANSPLANTATION FROM HL-A-MATCHED DONORS TO PATIENTS WITH ACUTE LEUKEMIA TOXICITY AND ANTILEUKEMIC EFFECT

R. G. Graw, Ronald A. Yankee, G. Nicholas Rogentine et al. · Transplantation · 1972 · 34 citations

Medicine, Hematology, Immunology +17

Front-line Treatment with Gemcitabine, Paclitaxel, and Doxorubicin for Patients With Unresectable or Metastatic Urothelial Cancer and Poor Renal Function: Final Results from a Phase II Study

Arlene O. Siefker‐Radtke, Matthew T. Campbell, Mark F. Munsell et al. · Urology · 2015 · 20 citations · Full text

Medicine, Oncology, Pharmacology +14

Abstract S3-02: NSABP B-36: A randomized phase III trial comparing six cycles of 5-fluorouracil (5-FU), epirubicin, and cyclophosphamide (FEC) to four cycles of adriamycin and cyclophosphamide (AC) in patients (pts) with node-negative breast cancer

Jacobs A Samuel, John Wilson, Hanna Bandos et al. · Cancer Research · 2015 · 19 citations

Medicine, Oncology, Pharmacology +9